Paper Details 
Original Abstract of the Article :
OBJECTIVE: Lenvatinib is a tyrosine kinase inhibitor that helps prevent angiogenesis. In this study, we investigated the potential influencing factors on lenvatinib pharmacokinetics to provide a reference for clinical application. MATERIALS AND METHODS: All healthy participants received a single do...See full text at original site
Dr.Camel IconDr.Camel's Paper Summary Blogラクダ博士について

ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。

* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。


引用元:
https://doi.org/10.5414/CP204440

データ提供:米国国立医学図書館(NLM)

The Influence of Diet and Gender on Lenvatinib Pharmacokinetics

Lenvatinib, a tyrosine kinase inhibitor used to prevent angiogenesis, is a powerful tool in the fight against cancer. However, like a camel traversing a desert, the journey of a drug through the body can be influenced by various factors, including diet and gender.

This study aimed to investigate the impact of these factors on lenvatinib pharmacokinetics, providing valuable insights for optimizing treatment strategies.

Exploring the Pharmacokinetic Landscape

Healthy participants received a single dose of lenvatinib with a high-fat meal or in a fasted state. The researchers meticulously measured lenvatinib plasma concentrations, revealing the impact of a high-fat diet on its pharmacokinetic profile. While the high-fat diet did alter the pharmacokinetic parameters, the study concluded that the changes were not significant enough to affect the drug's clinical efficacy.

Navigating the Desert of Pharmacokinetics

This study provides valuable information for clinicians. It suggests that lenvatinib can be administered under both fasted and fed conditions, offering flexibility in treatment schedules.

Dr. Camel's Conclusion

This study is a reminder that the journey of a drug through the body is a complex dance influenced by various factors. By understanding the influence of diet and gender on lenvatinib pharmacokinetics, we can navigate this intricate desert and optimize treatment strategies for our patients.

Date :
  1. Date Completed 2023-10-23
  2. Date Revised 2023-10-23
Further Info :

Pubmed ID

37644876

DOI: Digital Object Identifier

10.5414/CP204440

Related Literature

Article Analysis
SNS
PICO Info
in preparation
Languages

English

Positive IndicatorAn AI analysis index that serves as a benchmark for how positive the results of the study are. Note that it is a benchmark and requires careful interpretation and consideration of different perspectives.

This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.